Dinesh Mills

Vadodara, India Founded: 1935 • Age: 91 yrs Listed
Capsule manufacturing machines are produced by Dinesh Mills in India.

About Dinesh Mills

Dinesh Mills is a publicly listed company based in Vadodara (India) founded in 1935. Capsule manufacturing machines are produced by Dinesh Mills in India. The company has 322 employees. Its Indian entity Shri Dinesh Mills Limited reported revenue of β‚Ή79.95 Cr. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Dinesh Mills was established in 1935 in Vadodara, India, where operations center on the production of machinery for capsule manufacturing. The company serves the pharmaceutical equipment sector by providing machines used in capsule filling and production processes. Leadership is provided by Managing Director and Chairman Bharat Patel, with activities based primarily in the Indian market. Focus remains on industrial manufacturing standards and local operations.

  • Headquarters Vadodara, India
  • Employees 322
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website dineshmills.com
  • Social LinkedIn
  • Legal Name Shri Dinesh Mills Limited
  • Date of Incorporation 01 Jul, 1935
  • Jurisdiction Vadodara, Gujarat, India
Key Metrics
  • Market Cap
    ₹211 Cr

    SHRIDINE · BSE

  • Share Price
    ₹372.30

    -1.05% today

  • Revenue
    ₹67.72 Cr

    FY 2025-26 · +1.8% YoY

  • EBITDA
    −₹0.26 Cr

    Margin -0.4%

  • Net Profit
    ₹9.41 Cr

    FY 2025-26 · +37.4% YoY

  • P/E (TTM)
    15.3x

    P/B 1.0x

  • ROE
    4.7%

    ROCE 5.7%

  • Debt / Equity
    0.02

    Interest cover -23.0x

  • Employee Count
    322

Board of directors of Shri Dinesh Mills Limited (Dinesh Mills)

Shri Dinesh Mills Limited is the primary company behind Dinesh Mills. The board of Shri Dinesh Mills Limited currently have 8 directors; the longest-serving is Nimish Patel, appointed in 1995. 16 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Nimish Patel
DIN 00039549
Managing Director14 Jan 199531 yrs 10 moShri Dinesh Mills Limited
Bharat Upendra Patel
DIN 00039543
Managing Director01 Apr 201016 yrs 7 moShri Dinesh Mills Limited
Reshma Suresh Patel
DIN 00165162
Director15 Mar 20215 yrs 8 moShri Dinesh Mills Limited
Sameer Subhash Khera
DIN 00009317
Director23 May 20242 yrs 6 moShri Dinesh Mills Limited
Shivindersingh Chawla
DIN 02955805
Director23 May 20242 yrs 6 moShri Dinesh Mills Limited
Aditya Patel
DIN 03292506
Whole-time director23 May 20242 yrs 6 moShri Dinesh Mills Limited
Nishank Patel
DIN 05170801
Whole-time director23 May 20242 yrs 6 moShri Dinesh Mills Limited
Tejal Rahul Amin
DIN 00169860
Director28 Mar 20267 moShri Dinesh Mills Limited

People of Dinesh Mills

1 people are tracked at Dinesh Mills (1 in leadership); the tracked headcount is 322.

NameRoleGroup
Managing Director & ChairmanLeadership
Premium access

Complete people profiles for Dinesh Mills

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Dinesh Mills

Dinesh Mills is a publicly listed company on the BSE with ticker symbol SHRIDINE in India, operating in the Textiles sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date03 Sep 1970
  • Listed onBSE: 503804
  • Listed entityShri Dinesh Mills Limited
  • Exchange sectorTextiles

Financials of Dinesh Mills

Exchange-reported figures of Shri Dinesh Mills Ltd, the listed company behind Dinesh Mills (BSE: SHRIDINE).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹67.72 Cr
+1.8% YoY
EBITDA
−₹0.26 Cr
-114.5% YoY
Profit After Tax
₹9.41 Cr
+37.4% YoY
Net Worth
₹200 Cr
+3.1% YoY
Total Assets
₹208 Cr
-1.4% YoY
Total Debt
₹2.38 Cr
-50.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue67.7266.5367.1298.1790.1674.1666.16
Revenue growth+1.8%-0.9%-31.6%+8.9%+21.6%+12.1%-
EBITDA(0.26)1.792.5810.9616.8313.590.41
EBITDA margin-0.4%+2.7%+3.8%+11.2%+18.7%+18.3%+0.6%
Profit before tax8.4311.8560.2429.0736.5911.680.14
Net profit9.416.8511.947.9710.978.50(3.08)
Net profit margin+13.9%+10.3%+17.8%+8.1%+12.2%+11.5%-4.7%
EPS (β‚Ή)13.5718.7390.2542.3853.6117.532.07
Balance sheet
Total assets208211243193163129115
Net worth20019420215713811197.20
Total debt2.384.7723.8013.637.095.345.55
Cash & bank3.534.144.853.635.082.381.94
Net working capital8.40(21.42)16.8417.5622.9613.6110.50
Cash flow
Cash from operations3.0214.157.787.9813.0710.202.88
Cash from investing(0.01)2.69(9.38)(10.51)(10.98)(11.93)(3.39)
Cash from financing(3.52)(17.71)2.660.850.552.15(1.99)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue22.4018.1318.8515.5617.2616.0620.7316.22
Revenue growth (YoY)+29.8%+12.9%-9.1%-4.1%-25.0%-32.6%--
Other income1.206.842.313.552.494.323.941.93
EBITDA4.172.87(2.75)0.180.960.890.990.67
EBITDA margin+18.6%+15.8%-14.6%+1.2%+5.6%+5.5%+4.8%+4.1%
Depreciation0.650.670.760.710.690.660.760.80
Interest0.140.160.150.200.180.180.210.19
Profit before tax4.588.88(1.35)2.822.584.373.961.61
Tax1.631.41(0.79)0.520.650.651.210.94
Net profit2.957.47(0.56)2.301.933.722.750.67
EPS (β‚Ή)5.2713.342.613.515.786.753.701.18
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue67.3366.3066.8859.7155.1149.1246.81
Revenue growth+1.6%-0.9%+12.0%+8.4%+12.2%+4.9%-
EBITDA2.185.264.646.988.679.59(0.66)
EBITDA margin+3.2%+7.9%+6.9%+11.7%+15.7%+19.5%-1.4%
Profit before tax9.7414.3761.5228.1030.439.801.12
Net profit8.946.4214.157.317.937.53(2.43)
Net profit margin+13.3%+9.7%+21.2%+12.2%+14.4%+15.3%-5.2%
EPS (β‚Ή)15.5618.7685.5340.9747.3315.733.27
Balance sheet
Total assets205202212162143117105
Net worth197190197155137113101
Total debt2.384.775.36(1.01)(0.83)(0.61)(0.34)
Cash & bank2.331.551.332.914.712.001.54
Net working capital7.125.517.485.2814.228.328.24
Cash flow
Cash from operations3.151.97(9.14)22.2526.259.172.15
Cash from investing1.8316.086.87(19.48)(22.26)(11.68)(2.21)
Cash from financing(4.23)(18.16)0.61(4.60)(1.34)2.95(2.69)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue22.4018.0618.8515.4417.1815.8720.6616.15
Revenue growth (YoY)+30.4%+13.8%-8.8%-4.4%+16.8%+7.4%--
Other income0.906.462.033.152.064.043.471.86
Total expenses18.1715.0419.6415.2216.0514.4317.8416.90
EBITDA4.233.02(0.79)0.221.131.442.82(0.75)
EBITDA margin+18.9%+16.7%-4.2%+1.4%+6.6%+9.1%+13.6%-4.6%
Depreciation0.650.670.760.710.690.660.760.80
Interest0.140.160.150.200.180.180.210.19
Profit before tax4.348.650.332.462.324.645.320.12
Tax1.631.41(0.79)0.520.650.651.210.94

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 22 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue22.4018.1318.8515.5617.2616.0620.7316.22
Revenue growth (YoY)+29.8%+12.9%-9.1%-4.1%-25.0%-32.6%--
Other income1.206.842.313.552.494.323.941.93
EBITDA4.172.87(2.75)0.180.960.890.990.67
EBITDA margin+18.6%+15.8%-14.6%+1.2%+5.6%+5.5%+4.8%+4.1%
Depreciation0.650.670.760.710.690.660.760.80
Interest0.140.160.150.200.180.180.210.19
Profit before tax4.588.88(1.35)2.822.584.373.961.61
Tax1.631.41(0.79)0.520.650.651.210.94
Net profit2.957.47(0.56)2.301.933.722.750.67
EPS (β‚Ή)5.2713.342.613.515.786.753.701.18
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue67.7266.5367.1298.1790.1674.1666.16
Revenue growth+1.8%-0.9%-31.6%+8.9%+21.6%+12.1%-
Other income12.2313.8560.6325.3925.584.807.60
Total expenses67.9864.7464.5487.2173.3360.5765.75
Employee cost24.5123.2822.2422.9821.3719.2319.81
EBITDA(0.26)1.792.5810.9616.8313.590.41
EBITDA margin-0.4%+2.7%+3.8%+11.2%+18.7%+18.3%+0.6%
Depreciation2.833.022.815.775.175.897.05
Interest0.710.770.161.510.650.820.82
Profit before tax8.4311.8560.2429.0736.5911.680.14
Tax1.023.8713.615.173.931.00(0.61)
Net profit9.416.8511.947.9710.978.50(3.08)
Net profit margin+13.9%+10.3%+17.8%+8.1%+12.2%+11.5%-4.7%
EPS (β‚Ή)13.5718.7390.2542.3853.6117.532.07
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital5.605.666.026.015.995.605.30
Reserves & surplus19518919615113210590.77
Shareholders' funds (net worth)20019420215713811197.20
Minority interest0.004.987.4911.4211.258.597.74
Secured loans2.384.7723.8013.637.095.345.39
Unsecured loans0.000.000.000.000.000.000.16
Total debt2.384.7723.8013.637.095.345.55
Total liabilities208211243193163129115
Assets
Gross block135141194185177171178
Net block22.1224.1354.5648.9643.7439.1945.19
Capital work in progress0.000.000.000.000.000.000.00
Investments17115816311692.2473.8458.05
Inventories14.7115.8019.4415.8718.8716.2714.58
Sundry debtors4.975.3415.1414.8613.8210.6711.76
Cash & bank balances3.534.144.853.635.082.381.94
Loans & advances5.956.385.349.418.561.742.62
Total current assets29.1631.6644.7743.7746.3331.0630.90
Total current liabilities20.7653.0827.9326.2123.3717.4520.40
Net working capital8.40(21.42)16.8417.5622.9613.6110.50
Total assets208211243193163129115
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash3.314.193.144.812.171.754.25
Net cash from operating activities3.0214.157.787.9813.0710.202.88
Net cash from investing activities(0.01)2.69(9.38)(10.51)(10.98)(11.93)(3.39)
Net cash from financing activities(3.52)(17.71)2.660.850.552.15(1.99)
Net change in cash(0.51)(0.88)1.05(1.68)2.640.42(2.50)
Closing cash3.534.144.853.635.082.381.94
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+1.8%-0.9%-31.6%+8.9%+21.6%+12.1%-
EBITDA growth-114.5%-30.6%-76.5%-34.9%+23.8%+3214.6%-
PBT growth-28.9%-80.3%+107.2%-20.6%+213.3%+8242.9%+9998.0%
Net income growth+37.4%-42.6%+49.8%-27.4%+29.1%+376.0%-
Revenue CAGR (3Y)-11.6%-9.6%-3.3%+14.1%+0.3%-7.1%-11.8%
EBITDA CAGR (3Y)--52.6%-42.5%+199.0%+55.9%--64.4%
Profitability & leverage
Net income margin+10.9%+12.0%+69.5%+24.4%+36.2%+14.4%+1.1%
Return on capital employed+5.7%+5.7%+9.3%+6.4%+11.4%+9.5%+0.2%
Return on net worth+4.7%+4.0%+4.5%+5.5%+11.0%+9.0%-3.5%
Debt / equity0.020.070.100.070.050.050.07
Long-term debt / equity0.030.050.080.060.030.010.02
Interest cover-22.98-62.60-69.5729.095.5710.65-12.35
Efficiency & per share
Fixed asset turnover0.490.400.350.540.520.430.32
Inventory turnover4.443.783.805.655.134.813.54
Debtors turnover13.146.504.476.857.366.615.32
EPS (β‚Ή)13.5718.7390.2542.3853.6117.532.07
Dividend per share (β‚Ή)1.502.0030.0010.007.505.003.00
Book value per share (β‚Ή)357.62346.91359.72280.33245.76197.41181.24
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue22.4018.0618.8515.4417.1815.8720.6616.15
Revenue growth (YoY)+30.4%+13.8%-8.8%-4.4%+16.8%+7.4%--
Other income0.906.462.033.152.064.043.471.86
Total expenses18.1715.0419.6415.2216.0514.4317.8416.90
EBITDA4.233.02(0.79)0.221.131.442.82(0.75)
EBITDA margin+18.9%+16.7%-4.2%+1.4%+6.6%+9.1%+13.6%-4.6%
Depreciation0.650.670.760.710.690.660.760.80
Interest0.140.160.150.200.180.180.210.19
Profit before tax4.348.650.332.462.324.645.320.12
Tax1.631.41(0.79)0.520.650.651.210.94
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue67.3366.3066.8859.7155.1149.1246.81
Revenue growth+1.6%-0.9%+12.0%+8.4%+12.2%+4.9%-
Other income11.1012.9059.8524.7225.304.647.42
Total expenses65.1561.0462.2452.7346.4439.5347.47
Employee cost24.5123.2822.2418.2616.6415.8316.54
EBITDA2.185.264.646.988.679.59(0.66)
EBITDA margin+3.2%+7.9%+6.9%+11.7%+15.7%+19.5%-1.4%
Depreciation2.833.022.813.453.414.235.43
Interest0.710.770.160.150.130.200.21
Profit before tax9.7414.3761.5228.1030.439.801.12
Tax1.023.8713.615.173.931.00(0.61)
Net profit8.946.4214.157.317.937.53(2.43)
Net profit margin+13.3%+9.7%+21.2%+12.2%+14.4%+15.3%-5.2%
EPS (β‚Ή)15.5618.7685.5340.9747.3315.733.27
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital5.605.605.605.605.605.605.30
Reserves & surplus19218419115013110894.42
Shareholders' funds (net worth)197190197155137113101
Secured loans2.384.775.36(1.01)(0.83)(0.61)(0.34)
Unsecured loans0.000.000.000.000.000.000.00
Total debt2.384.775.36(1.01)(0.83)(0.61)(0.34)
Total liabilities205202212162143117105
Assets
Gross block135141137128130132140
Net block22.1224.1322.8815.7517.0319.4424.41
Capital work in progress0.000.000.000.000.000.000.00
Investments16915817413110887.3971.25
Inventories14.7115.8015.4011.9713.3612.9112.39
Sundry debtors4.925.275.225.284.945.197.16
Cash & bank balances2.331.551.332.914.712.001.54
Loans & advances5.916.304.745.907.271.442.49
Total current assets27.8728.9226.6926.0630.2821.5423.58
Total current liabilities20.7523.4119.2120.7816.0613.2215.34
Net working capital7.125.517.485.2814.228.328.24
Total assets205202212162143117105
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.860.972.634.451.791.354.10
Net cash from operating activities3.151.97(9.14)22.2526.259.172.15
Net cash from investing activities1.8316.086.87(19.48)(22.26)(11.68)(2.21)
Net cash from financing activities(4.23)(18.16)0.61(4.60)(1.34)2.95(2.69)
Net change in cash0.75(0.11)(1.66)(1.82)2.650.45(2.76)
Closing cash2.331.551.332.914.712.001.54
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+1.6%-0.9%+12.0%+8.4%+12.2%+4.9%-
EBITDA growth-58.6%+13.4%-33.5%-19.5%-9.6%+1553.0%-
PBT growth-32.2%-76.6%+118.9%-7.7%+210.5%+775.0%+9998.0%
Net income growth+39.3%-54.6%+93.6%-7.8%+5.3%+409.9%-
Revenue CAGR (3Y)+4.1%+6.4%+10.8%+8.5%-7.1%-13.9%-16.1%
EBITDA CAGR (3Y)-32.2%-15.3%-21.5%-+42.8%--
Profitability & leverage
Net income margin+13.0%+15.8%+71.6%+38.4%+48.1%+17.9%+3.7%
Return on capital employed+5.1%+5.8%+9.8%+5.5%+6.8%+7.6%-2.7%
Return on net worth+4.5%+3.3%+8.0%+5.0%+6.4%+7.1%-2.4%
Debt / equity0.020.030.01-0.01-0.010.000.00
Long-term debt / equity0.030.030.010.000.000.000.00
Interest cover-109.2334.388.744.252.473.73-3.45
Efficiency & per share
Fixed asset turnover0.490.480.500.460.420.360.27
Inventory turnover4.414.254.894.714.203.882.90
Debtors turnover13.2112.6412.7411.6810.887.956.64
EPS (β‚Ή)15.5618.7685.5340.9747.3315.733.27
Dividend per share (β‚Ή)1.502.0030.0010.007.505.003.00
Book value per share (β‚Ή)352.14339.08351.74277.37244.26202.13188.13

Similar companies to Dinesh Mills

Dinesh Mills has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Dinesh Mills

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Dinesh Mills

Websites that share an audience with Dinesh Mills (dineshmills.com).

Similar websites

Websites whose visitors overlap most with Dinesh Mills. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
zjhuading.com
100%
View details
bruch.be
bruch.be
100%
–
ik-felt.co.jp
100%
5.4K#3,188,476View details
wrt-belt.com
wrt-belt.com
100%
–
polyestermesh.net
polyestermesh.net
100%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 15 similar websites and full traffic analytics for Dinesh Mills

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 15 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Dinesh Mills (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Dinesh Mills

Premium access

Complete news archive for Dinesh Mills

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dinesh Mills

Dinesh Mills was founded in 1935.

Dinesh Mills is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.

Dinesh Mills has 322 employees.

The primary company behind Dinesh Mills, Shri Dinesh Mills Limited, reported revenue of β‚Ή79.95 Cr for FY 2026, up 2% year on year.

Dinesh Mills was established in 1935 in Vadodara, India, where operations center on the production of machinery for capsule manufacturing. The company serves the pharmaceutical equipment sector by providing machines used in capsule filling and production processes. Leadership is provided by Managing Director and Chairman Bharat Patel, with activities based primarily in the Indian market. Focus remains on industrial manufacturing standards and local operations.

Dinesh Mills's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Yes, Dinesh Mills is publicly traded on BSE under the ticker symbol SHRIDINE.

Dinesh Mills operates through Shri Dinesh Mills Limited.

The legal entities of Dinesh Mills currently have 10 directors, including Bharat Upendra Patel, Reshma Suresh Patel, Mohan Vyankatesh Akalkotkar and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available